- Previous Close
9.84 - Open
9.74 - Bid --
- Ask 9.31 x --
- Day's Range
9.10 - 9.75 - 52 Week Range
8.10 - 17.34 - Volume
93,832 - Avg. Volume
67,914 - Market Cap (intraday)
379.762M - Beta (5Y Monthly) 0.96
- PE Ratio (TTM)
-- - EPS (TTM)
-0.18 - Earnings Date --
- Forward Dividend & Yield 0.50 (5.08%)
- Ex-Dividend Date Apr 25, 2025
- 1y Target Est
19.00
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through Healthcare; and Consumer and Industrial segments. The company offers dental products, including mixing tips and cartridges for various applications, such as prosthetics, restorations, anesthetics, and aesthetics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. It also produces and markets dispensers, mixing tips, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics assembly, infrastructure, and general industrial industries; and micro-brushes used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments, such as anti-aging treatments. It offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. medmix AG was founded in 1922 and is based in Baar, Switzerland.
www.medmix.swiss2,684
Full Time Employees
December 31
Fiscal Year Ends
Sector
Specialty Industrial Machinery
Industry
Recent News: MEDX.SW
View MorePerformance Overview: MEDX.SW
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDX.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDX.SW
View MoreValuation Measures
Market Cap
401.38M
Enterprise Value
628.58M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.84
Price/Book (mrq)
0.92
Enterprise Value/Revenue
1.30
Enterprise Value/EBITDA
9.34
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.53%
Return on Assets (ttm)
1.22%
Return on Equity (ttm)
-1.39%
Revenue (ttm)
483.9M
Net Income Avi to Common (ttm)
-7.4M
Diluted EPS (ttm)
-0.18
Balance Sheet and Cash Flow
Total Cash (mrq)
118.1M
Total Debt/Equity (mrq)
73.70%
Levered Free Cash Flow (ttm)
58.44M